PhD student
Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University, Czech Republic
Pedro Faria Zeni is a biomedical researcher affiliated with the Central European Institute of Technology (CEITEC - Masaryk University) and University Hospital Brno, where he is pursuing his PhD at the MRAZ LAB (Microenvironment of Immune Cells). He holds a degree in Biomedicine and a Master’s degree in Functional and Molecular Biology from Brazil. Additionally, Pedro is a specialist in genomic data science, having completed the Johns Hopkins University Genomic Data Science specialization on Coursera.
His research focuses on the role of long non-coding RNAs (lncRNAs) in chronic lymphocytic leukemia (CLL), particularly their involvement in B-cell receptor (BCR)-mediated CLL activation. Pedro has made significant contributions to important studies, including investigations into the modulation of miR-29 in CD40 signaling, the role of lncRNAs in adaptive immunity, and the mechanisms of ibrutinib resistance through the FoxO1/Rictor axis. Driven by a passion for understanding cancer at the molecular level, Pedro aims to uncover novel strategies to combat this disease. His current work at CEITEC explores the emerging field of lncRNAs, which holds great promise for revealing new insights into cancer biology.
